Target intelligence / Profile preview

Dermal-epidermal junction (DEJ) (DEJ)

Target
DEJ
Molecular classification
Not applicable - DEJ is a composite anatomical structure, not a single molecule or receptor.
01

Overview

The dermal-epidermal junction is a specialized anatomical interface between the epidermis and dermis composed of multiple interacting structural proteins that form the basement membrane zone[1][3]. Rather than being a single therapeutic target, the DEJ is a complex structural zone made up of numerous protein components including hemidesmosomes, anchoring filaments, basement membrane proteins (collagens IV, VII, and XVII; laminins; nidogen; perlecan), and anchoring fibrils[1][3][6]. The DEJ serves critical functions in skin homeostasis including epidermal-dermal adherence, mechanical support, regulation of the cellular microenvironment, and acting as a barrier to molecular exchange[1][3]. The structure exhibits a characteristic corrugated topography with rete ridges and dermal papillae that enhance mechanical resistance and nutrient exchange between the vascularized dermis and avascular epidermis[3]. While individual proteins within the DEJ (such as collagen VII and collagen IV) may be targeted in therapeutic approaches, the DEJ itself is an organizational structure rather than a single molecular target[7][8].

Other names
Dermoepidermal junctionepidermal-dermal junctionbasement membrane zone (BMZ)
02

Mechanism of action

Not applicable

03

Biological functions

Structural integritymechanical supportcell adhesionnutrient/waste exchangestem cell niche maintenancebarrier function
04

Disease associations

Epidermolysis bullosa (mutations in DEJ proteins)psoriasis (rete ridge alterations)age-related skin changesskin cancer
05

Safety considerations

Not applicable for direct targeting
06

Biomarkers

Collagen VII and collagen IV integrityrete ridge morphologyhemidesmosome density

Beyond the preview

Go deeper on Dermal-epidermal junction (DEJ) (DEJ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermal-epidermal junction (DEJ) (DEJ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call